A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R ...

EndoTheia announced today that it completed the first-in-human clinical trial for its FlexStone basket, a steerable kidney ...

Approximately 16% of the global population, or about 890 million people, suffer from obesity. The World Health Organization ...

The National Institutes of Health (NIH) has unveiled a new artificial intelligence (AI) algorithm designed to more ...

The World Institute of Kimchi(WIKIM) has announced that the regular consumption of kimchi, a traditional Korean fermented ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.

Barbara O’Brien, MD, discusses the background behind the phase 2 TBCRC049 study investigating the combination of tucatinib, trastuzumab, and capecitabine for the treatment of patients with ...

Viking Therapeutics (VKTX) announced that results from the company’s Phase 2b clinical trial of VK2809, the company’s novel liver-selective ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...